The customer reported that the thermogard xp ivtm system (s/n (b)(4)) was slowly warming the patient while in controlled rate mode.It is unknown what type of catheter was used and whether the catheter was replaced before initiating the rewarming phase.The customer did not provide additional information on whether there were any kinks, bends, or occlusions in suk and/or the catheter.No secondary temperature probe was used.No further information was provided.No consequences or impact to the patient.
|
Patient data files were reviewed by the zoll service personnel.The patient's body temperature had been well maintained at 36 °c in max mode for about 24 hours before the controlled rate was selected at the target temperature of 36.5 °c.The patient's body temperature was 35.98 °c when controlled-rate-rewarming was started.It is unknown why the customer chose a controlled rate so close to the warming target temperature of 36.5 °c.During the rewarming phase of the treatment, the customer set the console first to a controlled rate of 0.15 °c/hour, then to 0.2 °c/hour, then to max, then to 0.15 °c/hour, and then to max again.The therapy ended when the patient's body temperature was 36.47 °c.The thermogard xp ivtm system (s/n (b)(4)) involved in the reported complaint will not be returned to zoll for evaluation and was not evaluated at the customer site because the customer/biomed tested the system, and the console passed functional testing.Therefore, the thermogard console was placed back for clinical use, and service was not required to be performed by zoll.
|